{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:03:36Z","timestamp":1775793816595,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jcv.2012.12.004","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T07:08:01Z","timestamp":1357196881000},"page":"336-341","source":"Crossref","is-referenced-by-count":28,"title":["Serum antibodies to human papillomavirus (HPV) pseudovirions correlate with natural infection for 13 genital HPV types"],"prefix":"10.1016","volume":"56","author":[{"given":"Helena","family":"Faust","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateja M.","family":"Jelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Poljak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Klavs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"U\u010dakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jcv.2012.12.004_bib0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2008","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.jcv.2012.12.004_bib0010","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"issue":"9447","key":"10.1016\/j.jcv.2012.12.004_bib0015","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jcv.2012.12.004_bib0020","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2012.12.004_bib0025","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ygyno.2010.04.002","article-title":"Potential mechanisms for HPV vaccine-induced long-term protection","volume":"118","author":"Stanley","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.jcv.2012.12.004_bib0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3851\/IMP1941","article-title":"New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention","volume":"17","author":"Gersch","year":"2012","journal-title":"Antivir Ther"},{"issue":"5","key":"10.1016\/j.jcv.2012.12.004_bib0035","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/aje\/kwg171","article-title":"Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study","volume":"158","author":"Molano","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.jcv.2012.12.004_bib0040","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1086\/315498","article-title":"Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection","volume":"181","author":"Carter","year":"2000","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jcv.2012.12.004_bib0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1055-9965.EPI-03-0191","article-title":"Natural history of human papillomavirus type 16 virus-like particle antibodies in young women","volume":"13","author":"Ho","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.jcv.2012.12.004_bib0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/scbi.1999.0146","article-title":"The serological response to papillomaviruses","volume":"9","author":"Dillner","year":"1999","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1016\/j.jcv.2012.12.004_bib0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jadohealth.2011.10.010","article-title":"Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review","volume":"50","author":"Tiggelaar","year":"2012","journal-title":"J Adolesc Health"},{"issue":"6","key":"10.1016\/j.jcv.2012.12.004_bib0060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ijc.10153","article-title":"Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer","volume":"97","author":"Combita","year":"2002","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.jcv.2012.12.004_bib0065","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.bjc.6601272","article-title":"Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10,000 women in Costa Rica","volume":"89","author":"Wang","year":"2003","journal-title":"Br J Cancer"},{"issue":"Pt 7","key":"10.1016\/j.jcv.2012.12.004_bib0070","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1099\/vir.0.019349-0","article-title":"Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin-coated beads","volume":"91","author":"Faust","year":"2010","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.jcv.2012.12.004_bib0075","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/JCM.00012-11","article-title":"Comparison of clinical and analytical performance of the abbott realtime high risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening","volume":"49","author":"Poljak","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.jcv.2012.12.004_bib0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vaccine.2011.10.066","article-title":"Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study","volume":"30","author":"Ucakar","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jcv.2012.12.004_bib0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/(SICI)1097-0215(19990209)80:4<489::AID-IJC1>3.0.CO;2-9","article-title":"A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children","volume":"80","author":"af Geijersstam","year":"1999","journal-title":"Int J Cancer"},{"issue":"Pt 2","key":"10.1016\/j.jcv.2012.12.004_bib0090","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1099\/0022-1317-80-2-391","article-title":"Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study","volume":"80","author":"Kjellberg","year":"1999","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.jcv.2012.12.004_bib0095","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/JVI.78.2.751-757.2004","article-title":"Efficient intracellular assembly of papillomaviral vectors","volume":"78","author":"Buck","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.jcv.2012.12.004_bib0100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.vaccine.2011.10.096","article-title":"International collaborative proficiency study of human papillomavirus type 16 serology","volume":"30","author":"Eklund","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jcv.2012.12.004_bib0105","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1128\/JCM.41.6.2509-2514.2003","article-title":"General acquisition of human papillomavirus infections of skin occurs in early infancy","volume":"41","author":"Antonsson","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.jcv.2012.12.004_bib0110","doi-asserted-by":"crossref","first-page":"e1000091","DOI":"10.1371\/journal.ppat.1000091","article-title":"Seroprevalence of 34 human papillomavirus types in the German general population","volume":"4","author":"Michael","year":"2008","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.jcv.2012.12.004_bib0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcv.2010.10.015","article-title":"Serological evidence of Merkel cell polyomavirus primary infections in childhood","volume":"50","author":"Chen","year":"2011","journal-title":"J Clin Virol"},{"issue":"8","key":"10.1016\/j.jcv.2012.12.004_bib0120","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/infdis\/jiq173","article-title":"Antibodies to merkel cell polyomavirus correlate to presence of viral DNA in the skin","volume":"203","author":"Faust","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jcv.2012.12.004_bib0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.vaccine.2008.10.088","article-title":"Immunogenicity and tolerability of an HPV-16\/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15\u201355 years","volume":"27","author":"Schwarz","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.12.004_bib0130","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00840-12","article-title":"The 2010 global proficiency study of human papillomavirus genotyping in vaccinology","author":"Eklund","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.jcv.2012.12.004_bib0135","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16\u201326 years","volume":"199","author":"Brown","year":"2009","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jcv.2012.12.004_bib0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4161\/hv.3.4.4058","article-title":"Antibodies from women immunized with gardasil cross-neutralize HPV 45 pseudovirions","volume":"3","author":"Smith","year":"2007","journal-title":"Hum Vaccin"},{"issue":"1","key":"10.1016\/j.jcv.2012.12.004_bib0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Wheeler","year":"2011","journal-title":"Lancet Oncol"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653212004441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653212004441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T15:27:02Z","timestamp":1539962822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653212004441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1386653212004441"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2012.12.004","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}